title: Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
authors.affiliation: 1 Médecins Sans Frontières Paris, France.
authors.forename: Francis
authors.initials: F
authors.lastname: Varaine
authors.affiliation: 1 Médecins Sans Frontières Paris, France.|2 Sorbonne Université, Université Pierre et Marie Curie, INSERM, Centre d'Immunologie et des Maladies Infectieuses Paris, France.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Guglielmetti
authors.affiliation: 3 Epicentre Paris, France.
authors.forename: Helena
authors.initials: H
authors.lastname: Huerga
authors.affiliation: 3 Epicentre Paris, France.|4 Institut de Recherche pour le Développement, INSERM, Université de Montpellier Montpellier, France.
authors.forename: Maryline
authors.initials: M
authors.lastname: Bonnet
authors.affiliation: 5 National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia.
authors.forename: Nana
authors.initials: N
authors.lastname: Kiria
authors.affiliation: 6 Ministry of Health Nairobi, Kenya.
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Sitienei
authors.affiliation: 7 Brigham and Women's Hospital Boston, Massachusetts and.
authors.forename: Michael
authors.initials: M
authors.lastname: Rich
authors.affiliation: 8 Harvard Medical School Boston, Massachusetts.
authors.forename: Carole D
authors.initials: CD
authors.lastname: Mitnick
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002985:Clinical Protocols / Q000592:standards*; D004334:Drug Administration Schedule; D004608:Eligibility Determination / Q000592:standards*; D006801:Humans; D017410:Practice Guidelines as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents